Provided by Tiger Trade Technology Pte. Ltd.

Scinai Immunotherapeutics Ltd.

1.63
-0.0800-4.68%
Volume:40.25K
Turnover:66.95K
Market Cap:1.15M
PE:-0.33
High:1.69
Open:1.68
Low:1.60
Close:1.71
52wk High:16.40
52wk Low:1.60
Shares:706.60K
Float Shares:435.60K
Volume Ratio:0.13
T/O Rate:9.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8918
EPS(LYR):59.48
ROE:-26.53%
ROA:-36.15%
PB:0.19
PE(LYR):0.03

Loading ...

Scinai Immunotherapeutics refocuses capital on NanoAb platform and CDMO business

TIPRANKS
·
Sep 08

Scinai Swings to FY26 H1 Net Income of USD 1.57 Million; Operating Loss Widens to USD 4.61 Million

Reuters
·
Aug 24

Press Release: Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum

Dow Jones
·
Aug 24

NASDAQ Trade Halt Continues Reason not Available at 07:55 Am

Reuters
·
Aug 21

Press Release: Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

Dow Jones
·
Aug 10

Scinai Q1 FY26 returns to profit at USD 3.58 million; revenue falls to USD 489,000

Reuters
·
Jun 10

Press Release: Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives

Dow Jones
·
Jun 10

Scinai names Eilon Elmalem site head of Yavne CDMO facility

Reuters
·
May 20

Press Release: Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Dow Jones
·
May 20

ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 62%

Dow Jones
·
Apr 25

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

Reuters
·
Apr 24

Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today?

TIPRANKS
·
Apr 24

Scinai Immunotherapeutics announces $2.61M private placement

TIPRANKS
·
Apr 24

Press Release: Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Dow Jones
·
Apr 24

Scinai Immunotherapeutics completes strategic reorganization

TIPRANKS
·
Apr 06

Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Benzinga Earnings
·
Apr 01

Scinai Immunotherapeutics highlights expanded CDMO platform

TIPRANKS
·
Mar 19